solid

Documents about solid

• TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)#181781ClinicalTrials.gov
• AO-176 in Multiple Solid Tumor Malignancies#123474ClinicalTrials.gov
• MAQ-001 in Patients With Advanced Solid Tumors#300259ClinicalTrials.gov
• MAX-10181 in Patients With Advanced Solid Tumor#363591ClinicalTrials.gov
• Ex Vivo Expansion (ACT-X)#481786ClinicalTrials.gov
• Effect of fuel–to–oxidizer ratio on HAN–based electric solid propellants#212148RUcore, Rutgers University Community Repository
• Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)#272361ClinicalTrials.gov
• Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor#148749ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy#353268ClinicalTrials.gov
• SW-682 in Advanced Solid Tumors#152393ClinicalTrials.gov
• Novel manufacturing routes for solid-state batteries#247992Ora Oxford University Research
• Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies#195327ClinicalTrials.gov
• Tailoring Silicon-Based LGPS-Type Solid Electrolytes for All-Solid-State Lithium Batteries#449079JLUpub
• MAX-10181 Given Orally to Patients With Advanced Solid Tumor#28313ClinicalTrials.gov
• MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.#234404ClinicalTrials.gov
• FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#279502ClinicalTrials.gov
• NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors#311137ClinicalTrials.gov
• CD8 PET Imaging in Metastatic Solid Tumours#346909ClinicalTrials.gov
• Allogeneic WTX-212C in Advanced Solid Tumors#346929ClinicalTrials.gov
• A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors#432882ClinicalTrials.gov
• Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations#448269ClinicalTrials.gov
• Personalized Neoantigen Cancer Vaccine for Patients with Solid Tumors#18708ClinicalTrials.gov
• Plasmodium Immunotherapy for Advanced Malignant Solid Tumors#158209ClinicalTrials.gov
• Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors#184868ClinicalTrials.gov
• MASCT-I Treatment for Advanced Solid Tumor#279526ClinicalTrials.gov
• RACIN in Patients With Advanced TIL-negative Solid Tumors#325310ClinicalTrials.gov
• Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification#329517ClinicalTrials.gov
• MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers#329576ClinicalTrials.gov
• Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors#18705ClinicalTrials.gov
• Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression#256893ClinicalTrials.gov
• Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors#451465ClinicalTrials.gov
• Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors#474749ClinicalTrials.gov
• Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors#123412ClinicalTrials.gov
• Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors#249599ClinicalTrials.gov
• Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors#261327ClinicalTrials.gov
• Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy#390932ClinicalTrials.gov
• Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors#407795ClinicalTrials.gov
• NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors#121431ClinicalTrials.gov
• Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies#181744ClinicalTrials.gov
• Study of AMV564 in Subjects With Advanced Solid Tumors#208433ClinicalTrials.gov
• Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor#451466ClinicalTrials.gov
• DEVELOPMENT OF COMPOSITE POLYMER ELECTROLYTES AND CATHODE MATERIALS FOR SOLID-STATE SODIUM-ION BATTERIES#292282ScholarBank@NUS
• Systematic Optimization and Characterization of All-Solid-State Batteries with Slurry-Cast Cathode#384978JLUpub
• Inorganic sodium solid-state electrolytes: progress, existing issues, and solutions towards high-performance all solid-state batteries#295975Spiral
• What a Waste 2.0: A Global Snapshot of Solid Waste Management to 2050#7455OpenAlex
• Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma#303738ClinicalTrials.gov
• Influence of the seasonal winds and the CO 2 mass exchange between atmosphere and polar caps on Mars' rotation#464205HAL (France)
• EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors#121467ClinicalTrials.gov
• A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors#148755ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic Solid Tumors#321565ClinicalTrials.gov

Related topics